Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022

Latest Articles

  • You have access
    Mitochondrial cytopathy in adults: What we know so far
    Bruce H. Cohen, MD and Deborah R. Gold, MD
    Cleveland Clinic Journal of Medicine July 2001, 68 (7) 625-642;

    The manifestations of mitochondrial cycopathy are remarkably diverse, and the syndromes identified so far probably represent only a few of the disorders.

  • You have access
    Use of cholinesterase inhibitors for treatment of Alzheimer disease
    Ann Marie Hake, MD
    Cleveland Clinic Journal of Medicine July 2001, 68 (7) 608-616;

    These drugs may slow but do not halt disease progression. They may be most beneficial if started early.

  • You have access
    Maximizing response to erythropoietin in treating HIV-associated anemia
    Onyekachi Ifudu, MBBS, MSc
    Cleveland Clinic Journal of Medicine July 2001, 68 (7) 643-648;

    A number of treatable factors can impair the response to erythropoietin in HIV patients.

  • You have access
    A 47-year-old man with a sore throat
    Michael Zapor, MD, PhD and Susan L. Fraser, MD
    Cleveland Clinic Journal of Medicine July 2001, 68 (7) 605-606;

    Questions and answers on the visible signs of diseases.

  • Cholesterol: What you need to know
    You have access
    Cholesterol: What you need to know
    Cleveland Clinic Journal of Medicine July 2001, 68 (7) 623-624;
  • You have access
    A young woman with fever, headache, and lymphadenopathy
    Roy F. Chemaly, MD and Susan J. Rehm, MD
    Cleveland Clinic Journal of Medicine July 2001, 68 (7) 584-593;

    What is the cause of this patient’s symptoms? A self-test on a clinical case.

  • You have access
    Trends in hospital medicine: Hospitalist advantages revealed
    Franklin A. Michota, MD
    Cleveland Clinic Journal of Medicine July 2001, 68 (7) 659-662;

    Available data indicate that hospitalists reduce health care costs while providing care of at least equal quality to that provided by primary care physicians.

  • How should hyperuricemia be treated in a patient with allopurinol hypersensitivity?
    You have access
    How should hyperuricemia be treated in a patient with allopurinol hypersensitivity?
    Stefan D. Monev, MD
    Cleveland Clinic Journal of Medicine July 2001, 68 (7) 597-598;

    If other methods of lowering uric acid fail, desensitization to allopurinol is an option but poses serious risks.

  • You have access
    New cholesterol guidelines: Better, but harder to follow
    Brian Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine July 2001, 68 (7) 579;

    The new guidelines on lowering cholesterol are good in theory but may prove cumbersome in practice.

  • You have access
    Using the new cholesterol guidelines in everyday practice
    Dennis L. Sprecher, MD and Joseph P. Frolkis, MD, PhD
    Cleveland Clinic Journal of Medicine July 2001, 68 (7) 617-622;

    Many more patients have become candidates for lipid-lowering therapy under new guidelines recently released.

Pages

  • Previous
  • Next
  • 1
  • …
  • 400
  • 401
  • 402
  • 403
  • 404
  • 405
  • 406
  • 407
  • 408
  • …
  • 798

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2025 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire